Jove
Visualize
联系我们

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Immunoliposomes for Neuroblastoma: Review of the Past Experience and Design of a Novel Nanoparticle.

Anticancer research·2024
Same author

Sickle Cell Disease Related Vasculopathies and Early Evaluation in a Pediatric Population.

In vivo (Athens, Greece)·2024
Same author

Publisher Correction to: Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma.

Pediatric research·2023
Same author

Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma.

Pediatric research·2023
Same author

Pediatric Patients With Sickle Cell Disease at a Public Hospital: Nutrition, Compliance and Early Experience With L-Glutamine Therapy.

In vivo (Athens, Greece)·2022
Same author

Chemotherapy Can Synergize With Adoptive Immunotherapy to Inhibit Medulloblastoma Growth.

Anticancer research·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 13, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.8K

针对尤文肉瘤的免疫脂质组.

Daniel E Panosyan1, William S Panosyan2, Daron S Yacoubian2

  • 1UCLA College of Letters & Science, University of California, Los Angeles, CA, U.S.A.; danielpanosyan@ucla.edu.

Cancer genomics & proteomics
|October 28, 2025
PubMed
概括
此摘要是机器生成的。

这项研究提出了针对性免疫瘤 (IL) 的方法,用于转移性尤文肉瘤 (EWS) 治疗. 载有niraparib的抗CD99IL显示出选择性破坏EWS细胞的潜力,提供了一种新的精确医学方法.

关键词:
尤文肉瘤 (Ewing Sarcoma) 是一种癌症.在PARP中,PARP是PARP.对抗CD99抗体的抗体免疫性瘤组的免疫性瘤组.尼拉帕里布里布里布.

更多相关视频

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.9K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

相关实验视频

Last Updated: Jan 13, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.8K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.9K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

科学领域:

  • 在瘤学瘤学.
  • 纳米医学是一种纳米医学.
  • 精准医学是一门精准的医学.

背景情况:

  • 转移性尤文肉瘤 (EWS) 的死亡率很高,需要先进的治疗策略.
  • 精准医学提供针对性地根除癌细胞,改善患者的治疗结果.
  • EWS细胞表达CD99,一种诊断标记物,使其成为治疗的目标.

研究的目的:

  • 提出一种向性免疫脂质酶 (IL),能够选择性地结合并破坏EWS细胞.
  • 评估CD99作为在EWS治疗中针对IL的向配体的潜力.
  • 为了确定适合ILs的有效载荷,该有效载荷对EWS比正常细胞更有细胞毒性.

主要方法:

  • 利用R2基因组学平台分析CD99和PARP1在EWS和正常组织中的差异表达.
  • 进行了卡普兰-梅尔分析,以确定PARP1表达在EWS中的预后意义.
  • 根据PARP抑制剂的副作用概况,为拟议的IL选择了有效载荷.

主要成果:

  • 与正常组织相比,EWS样品的CD99表达率较高;内皮细胞的CD99表达率中等.
  • 复发性/转移性EWS显示PARP1表达明显高于原发性瘤,与较差的生存率相关.
  • 尼拉帕里布因其有利的副作用概况,特别是其较低的淋巴毒性而被选为有效载荷.

结论:

  • 具有抗CD99抗体的向免疫脂质体,并装载着尼拉帕里布,代表了对先进的EWS有前途的辅助疗法.
  • 预计100纳米的IL尺寸预计将提高血管透性和瘤热带性.
  • 进一步的临床前评估对于评估潜在的造血和内皮损伤至关重要.